drugset / Trial / NCT07058259
Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPD
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomized controlled trial aims to evaluate the effectiveness of acupuncture as an adjunctive non-pharmacological therapy in patients with stable COPD who continue to experience dyspnea despite optimal medical treatment.
Timeline
- Start
- 2024-11-15
- Primary completion
- 2025-06-30
- Completion
- 2026-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Beclomethasone | Small molecule | — | Inhaled |
| Background | Budesonide | Small molecule | — | Inhaled |
| Background | Fluticasone | Other / unclassified | — | Inhaled |
| Background | Formoterol | Other / unclassified | — | Inhaled |
| Background | Glycopyrronium | Unknown | — | Inhaled |
| Background | Indacaterol | Other / unclassified | — | Inhaled |
| Background | Olodaterol | Small molecule | — | Inhaled |
| Background | Salmeterol | Other / unclassified | — | Inhaled |
| Background | Tiotropium | Other / unclassified | — | Inhaled |
| Background | Umeclidinium | Other / unclassified | — | Inhaled |
| Background | Vilanterol | Other / unclassified | — | Inhaled |